Difficulty: Medium
Average Score: 75%
Practice
Indicate the antiparkinsonism drug which should be avoided in patients with glaucoma:
Correct answer
D
Rationale
In this scenario, the correct answer is D) Trihexyphenidyl. Trihexyphenidyl is an antiparkinsonism drug that belongs to the class of anticholinergic medications. These drugs can cause mydriasis (dilation of the pupil) and increase intraocular pressure, making them potentially harmful for patients with glaucoma. Glaucoma is a condition characterized by increased intraocular pressure, which can lead to optic nerve damage and vision loss.
Option A) Selegiline is a monoamine oxidase inhibitor used in the treatment of Parkinson's disease. While it is generally safe in patients with glaucoma, it is not the drug to avoid in this specific case.
Option B) Levodopa is the most effective drug for managing Parkinson's symptoms and does not directly affect intraocular pressure or worsen glaucoma.
Option C) Bromocriptine is a dopamine agonist used in the treatment of Parkinson's disease. It does not have a significant impact on intraocular pressure and is not contraindicated in patients with glaucoma.
Educationally, understanding the potential adverse effects of medications in specific patient populations is crucial for safe and effective pharmacological management. This knowledge helps healthcare providers make informed decisions to prevent potential harm and optimize patient outcomes. In the case of patients with glaucoma, avoiding drugs like Trihexyphenidyl that can exacerbate their condition is essential to provide comprehensive care.
Option A) Selegiline is a monoamine oxidase inhibitor used in the treatment of Parkinson's disease. While it is generally safe in patients with glaucoma, it is not the drug to avoid in this specific case.
Option B) Levodopa is the most effective drug for managing Parkinson's symptoms and does not directly affect intraocular pressure or worsen glaucoma.
Option C) Bromocriptine is a dopamine agonist used in the treatment of Parkinson's disease. It does not have a significant impact on intraocular pressure and is not contraindicated in patients with glaucoma.
Educationally, understanding the potential adverse effects of medications in specific patient populations is crucial for safe and effective pharmacological management. This knowledge helps healthcare providers make informed decisions to prevent potential harm and optimize patient outcomes. In the case of patients with glaucoma, avoiding drugs like Trihexyphenidyl that can exacerbate their condition is essential to provide comprehensive care.